Unstoppable: The Future of Biotech & Digital Health Investing
COVID-19 has ignited biotech and digital health investment activity – from telemedicine to drug trial technology to precision genomics. In 2020, biotech IPO’s continued to pique investor interest and venture capital fundraising in healthcare reached record levels- and 2021 shows no sign of abating. According to Crunchbase, there has been $4.1B+ in health-related investment deals this year...